The impact of improving haemophilia A management within the Spanish National Healthcare System: a social return on investment analysis. [PDF]
BMC Health Serv Res, 2022 Soto I +9 more
europepmc +1 more source
[Application of gene therapy in the treatment of hematological diseases: achievements, and economic and ethical aspects of the topic]. [PDF]
Rev Med Inst Mex Seguro SocDiaz-Garcia H +2 more
europepmc +1 more source
Effect of DNA methylation on inhibitor development in people with hemophilia A treated with FVIII concentrates. [PDF]
Res Pract Thromb HaemostChand H +5 more
europepmc +1 more source
[Epidemiology of hepatitis C virus infection in ColombiaEpidemiologia da infecção pelo vírus da hepatite C na Colômbia]. [PDF]
Rev Panam Salud Publica, 2021 López-Osorio MC, Beltrán M, Navas MC.
europepmc +1 more source
Hemophilic Pseudotumor of the Maxilla Secondary to Endodontic Treatment: Case Report and Systematic Review. [PDF]
Dent J (Basel)Quiroz-Gomez JR +5 more
europepmc +1 more source
Terapia génica ex vivo para hemofilia B mediante vectores no virales y células madre mesenquimales derivadas de tejido adiposo humano [PDF]
, 2013 Introduction. The current treatment for haemophilia, although safe and efficient, is only palliative and not curative, with many patients developing antibodies that render treatment inefficient. Stem cell-mediated gene therapy with non-viral vectors would represent an alternative to cure this disease. Objectives.
openaire +1 more source
Gene therapy as an innovative approach to the treatment of hemophilia B-a review. [PDF]
J Appl GenetWróblewska K +5 more
europepmc +1 more source